Terms: = Lymphoma AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Prognosis
5 results:
1. [Development of acute kidney injury prognostic model for critically ill patients based on MIMIC-III database].
Li M; Yang H; Yang W; Wei B; Zhang Y; Xie R; Chu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):949-954. PubMed ID: 34590562
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear fgfr2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850
[TBL] [Abstract] [Full Text] [Related]
3. Lack of Targetable fgfr2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
[TBL] [Abstract] [Full Text] [Related]
4. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract] [Full Text] [Related]
5. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract] [Full Text] [Related]
